Sanofi

JEVTANA

Manufacturer:

Sanofi

Jevtana HCPCS:

J9043

HCPCS Code Descriptor:

Injection, cabazitaxel, 1 mg

Category:

J Code

Jevtana NDCs:

00024-5824-11

Primary Type:

Oncology

Generic/Specialty Status:

Single-Source

Package Type:

Vial

Route of Administration:

Intravenous

Jevtana CPT Codes:

Potential CPT administration codes for Jevtana can be found at the following link.

Potential NDC Listing Errors:

Our team did not identify any potential listing errors/discrepancies for the NDCs mapped to this HCPCS code.

About Jevtana:

JEVTANA is an Oncology drug manufactured by Sanofi and administered via the Intravenous route of administration. The J Code: J9043 is aligned to the drug JEVTANA.

ACCESS PRICING AND MORE BY REGISTERING

J9043 Added Date:

January 1, 2012

J9043 Effective Date:

January 1, 2012

J9043 Termination Date:

HCPCS Active

Jevtana billing and coding information can be found through Sanofi at the link below:
Jevtana patient assistance information can be found through Sanofi’s CareASSIST at the URL: https://www.sanoficareassist.com/
JEVTANA prescribing information can be found at the link below:
Information regarding JEVTANA’s side effects can be found at MedlinePlus